Publications by authors named "Vicky Sandhu"

Claim this Profile
E
Elevated lymphocyte count at time of acute myeloid leukemia diagnosis is associated with shorter remission.
Merav Bar, Megan Othus, Hanahlyn M Park, Vicky Sandhu, Xueyan Chen

Leuk Lymphoma· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infusion of a non-HLA-matched ex-vivo expanded cord blood progenitor cell product after intensive acute myeloid leukaemia chemotherapy: a phase 1 trial.
Colleen Delaney, Filippo Milano, Laura Cicconi, Megan Othus, Pamela S Becker, Vicky Sandhu

Lancet Haematol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does outcome of second salvage therapy in relapsed or refractory acute myeloid leukemia depend on intensity of either first or second salvage therapy?
Daisuke Araki, Megan Othus, Roland B Walter, Pamela S Becker, Vicky Sandhu

Leuk Lymphoma· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of tosedostat with cytarabine or decitabine in newly diagnosed older patients with acute myeloid leukaemia or high-risk MDS.
Raya Mawad, Pamela S Becker, Paul Hendrie, Bart Scott, Brent L Wood, Vicky Sandhu

Br J Haematol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of acquired copy-neutral loss of heterozygosity in acute myeloid leukemia.
Christine M Gronseth, Scott E McElhone, Barry E Storer, Kathleen A Kroeger, Vicky Sandhu

Cancer· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I/II study of oral clofarabine plus low-dose cytarabine in previously treated acute myeloid leukaemia and high-risk myelodysplastic syndrome patients at least 60 years of age.
Sarah A Buckley, Raya Mawad, Ted A Gooley, Pamela S Becker, Vicky Sandhu

Br J Haematol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of allogeneic hematopoietic cell transplantation in first complete remission on post-relapse complete remission rate and survival in acute myeloid leukemia.
Daisuke Araki, Megan Othus, Roland B Walter, Vicky Sandhu, Brenda M Sandmaier

Haematologica· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Idarubicin, cytarabine, and pravastatin as induction therapy for untreated acute myeloid leukemia and high-risk myelodysplastic syndrome.
Mazyar Shadman, Raya Mawad, Carol Dean, Tara L Chen, Kathleen Shannon-Dorcy, Vicky Sandhu

Am J Hematol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relation of clinical response and minimal residual disease and their prognostic impact on outcome in acute myeloid leukemia.
Xueyan Chen, Hu Xie, Brent L Wood, Roland B Walter, John M Pagel, Vicky K Sandhu

J Clin Oncol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation between peripheral blood and bone marrow regarding FLT3-ITD and NPM1 mutational status in patients with acute myeloid leukemia.
Wei-Gang Tong, Vicky K Sandhu, Brent L Wood, Paul C Hendrie, Pamela S Becker

Haematologica· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outpatient bendamustine and idarubicin for upfront therapy of elderly acute myeloid leukaemia/myelodysplastic syndrome: a phase I/II study using an innovative statistical design.
Jack M Lionberger, John M Pagel, Vicky K Sandhu, Hu Xie, Mazyar Shadman

Br J Haematol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency of allogeneic hematopoietic cell transplantation among patients with high- or intermediate-risk acute myeloid leukemia in first complete remission.
Raya Mawad, Ted A Gooley, Vicky Sandhu, Jack Lionberger, Bart Scott

J Clin Oncol· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The NCI common toxicity criteria and treatment-associated mortality in acute myeloid leukemia.
Joshua R Veatch, Vicky Sandhu, Pamela S Becker, John M Pagel, Frederick R Appelbaum

Blood· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heparin cofactor II is more sensitive than antithrombin to secretory impairment arising from mutations introduced into its carboxy-terminal region.
Varsha Bhakta, Megan E Begbie, Anjalee Gupta, Vicky Sandhu, William P Sheffield

Thromb Res· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis